On April 15, 2025, the Hong Kong stock market closed with mixed results. The Hang Seng Index rose by 0.23%, while the Hang Seng Tech Index fell by 0.67%.
DualityBio-B surged by an impressive 116.70%, driven by positive clinical trial results for its new cancer treatment, which showed promising efficacy and safety profiles.
Zenergy rose by 6.08%, following the announcement of a major contract win for renewable energy projects in Southeast Asia.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。